Withdraw
Loading…
Novel regulation of hepatic lipid secretion and storage
Lu, Wei
This item's files can only be accessed by the System Administrators group.
Permalink
https://hdl.handle.net/2142/129686
Description
- Title
- Novel regulation of hepatic lipid secretion and storage
- Author(s)
- Lu, Wei
- Issue Date
- 2025-04-15
- Director of Research (if dissertation) or Advisor (if thesis)
- Wang, Bo
- Doctoral Committee Chair(s)
- Wang, Bo
- Committee Member(s)
- Nelson, Erik
- Spinella, Michael J
- Yang, Jing
- Department of Study
- Comparative Biosciences
- Discipline
- VMS - Comparative Biosciences
- Degree Granting Institution
- University of Illinois Urbana-Champaign
- Degree Name
- Ph.D.
- Degree Level
- Dissertation
- Keyword(s)
- Atherosclerosis, VLDL, ApoB lipidation, lipid droplet expansion
- Abstract
- The liver plays a critical role in lipid homeostasis, where lipids are either secreted as very-low-density lipoproteins (VLDL) or stored in lipid droplets. Previous studies have demonstrated a close relationship between VLDL and lipid droplet metabolism. Impaired VLDL secretion has been associated with increased lipid droplet formation, whereas lipid droplets serve as potential sources of substrates for VLDL secretion. However, the regulatory mechanisms linking these two processes remain poorly understood. Here, we identify SEC16B, a scaffold protein localized at the ER exit sites (ERES), as a key regulator of hepatic lipid secretion and storage. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) in SEC16B to be highly related to plasma lipid levels in humans. In mice, hepatic Sec16b deficiency reduces serum lipid levels by impairing MTP-independent VLDL lipidation and disrupting COPII-mediated intracellular trafficking. Additionally, SEC16B partially localizes at ER-lipid droplet contact sites, where it promotes lipid droplet expansion by facilitating the recruitment of ER proteins to lipid droplets. More importantly, Sec16b deletion significantly lowers serum lipids and decreases atherosclerotic lesion size in Ldlr null mice. Taken together, these findings uncover a novel mechanism coordinating VLDL and lipid droplet metabolism and highlight SEC16B as a promising therapeutic target for atherosclerosis.
- Graduation Semester
- 2025-05
- Type of Resource
- Thesis
- Handle URL
- https://hdl.handle.net/2142/129686
- Copyright and License Information
- Copyright 2025 Wei Lu
Owning Collections
Graduate Dissertations and Theses at Illinois PRIMARY
Graduate Theses and Dissertations at IllinoisManage Files
Loading…
Edit Collection Membership
Loading…
Edit Metadata
Loading…
Edit Properties
Loading…
Embargoes
Loading…